Madam Asiah, age 35, was admitted to the ward with generalized abdominal pain, more on the right side and back. She has stage IV bilateral breast cancer and is scheduled for surgery. The doctor wants assessments of nausea/vomiting due to chemotherapy and interventions to improve nutrition. Counseling will also be provided to address changes to her body image and self-esteem from the cancer treatments. Pain management interventions are needed to relieve her discomfort.
cancer of breast , this slide cointains detailed information about the breast cancer that is definition, causes and risk factor, sign and symptoms, management of patient with cancer , giving psychological support .treatment
Cancer is a life-threatening disease. 80% to 90% of all cancers are the result of the things we do to ourselves. Among women, breast cancer is the second most common cancer.
Endometrial cancer is a type of uterine cancer that starts in the inner lining of the uterus. This lining is called the endometrium.
According to the National Cancer Institute, approximately 3 in 100 women will be diagnosed with uterine cancer at some point in their lives. More than 80 percent of people with uterine cancer survive for five years or longer after receiving the diagnosis.
If you have endometrial cancer, early diagnosis and treatment increases your chances of remission.
cancer of breast , this slide cointains detailed information about the breast cancer that is definition, causes and risk factor, sign and symptoms, management of patient with cancer , giving psychological support .treatment
Cancer is a life-threatening disease. 80% to 90% of all cancers are the result of the things we do to ourselves. Among women, breast cancer is the second most common cancer.
Endometrial cancer is a type of uterine cancer that starts in the inner lining of the uterus. This lining is called the endometrium.
According to the National Cancer Institute, approximately 3 in 100 women will be diagnosed with uterine cancer at some point in their lives. More than 80 percent of people with uterine cancer survive for five years or longer after receiving the diagnosis.
If you have endometrial cancer, early diagnosis and treatment increases your chances of remission.
Detailed Powerpoint Presentation on Wilms Tumour …. It includes definition with images, causes, sign and symptoms all treatment modalities with nursing responsibilities and recent research related to this...
There are many types of cancer treatment. The types of treatment that patient receive will depend on the type of cancer, stage of cancer and how advanced it is.
Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy.
Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Breast cancer can occur in both men and women, but it's far more common in women.
Prostate cancer or tumor is the most common cancer in men other than non-melanoma skin cancer.
The majority (more than 75%) of cases occur in men over age 65.
Risk factors for prostate cancer including increasing age, the incidence of prostate cancer increase rapidly after the age of 50 years. And more than 70% cases occur in men older than 65 year of age.
Detailed Powerpoint Presentation on Wilms Tumour …. It includes definition with images, causes, sign and symptoms all treatment modalities with nursing responsibilities and recent research related to this...
There are many types of cancer treatment. The types of treatment that patient receive will depend on the type of cancer, stage of cancer and how advanced it is.
Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy.
Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Breast cancer can occur in both men and women, but it's far more common in women.
Prostate cancer or tumor is the most common cancer in men other than non-melanoma skin cancer.
The majority (more than 75%) of cases occur in men over age 65.
Risk factors for prostate cancer including increasing age, the incidence of prostate cancer increase rapidly after the age of 50 years. And more than 70% cases occur in men older than 65 year of age.
Breast Carcinoma.
Breast cancer is a malignant (cancerous) tumor that starts in the cells of the breast and spread to other tissues.
The most common form of cancer among women
It is estimated that each year more than 83,000 cases of breast cancer are reported in Pakistan. Nearly 40,000 women die, just due to this deadly disease
Carcinoma of the breast occurs commonly in the western world,accounting for 3–5% of all deaths in women. In developing countries it accounts for 1–3% of death
The most common form of cancer among women
The second most common cause of cancer related mortality
1 of 8 women (12.2%)
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. Breast cancer are common conditions that primarily
affect women.
When a women discovers a breast lump, her first
response is often fear, of breast cancer, of losing her
breast and perhaps of losing her life.
Breast cancer also strikes men although rarely.
Breast cancer is rarely seen in client under the age
of 40.
3. fibrocystic breast changes : term used to describe certain
benign changes in the breast, typically associated with
palpable nodularity, lumpiness, swelling, or pain
lymphedema : chronic swelling of an extremity due to
interrupted lymphatic circulatin, typically from an axillary
lymph node dissection
mastitis : inflammation or infection of the breast
paget’s disease : from of breast cancer begins in the ductal
system and involves the nipple, areola, and
surrounding skin
gynecomastia : overdeveloped breast tissue typically seen in
adolescent boys
4. Breast cancer is a malignant (cancerous)
growth that begins in the tissue of the
breast.
Cancer is a disease in which abnormal
cells grow in an uncontrolled way.
5. 1 . DUCTAL CARCINOMA IN SITU ( DCIS )
increase use of mammography as a screening tool has
contributed to the dramatic.
characterized by the proliferation of malignant cells
inside the milk ducts without invasion into the
surrounding tissue.
DCIS is frequently manifested on a mammogram with
the appearance of calcifications , and considered breast
cancer stage 0.
if untreated, increase likelihood that it will progress to
invasive cancer.
6. The most traditional treatment is total or
simple mastectomy ( removal of the breast
cancer) .
The trend today is toward less aggressive
surgery breast conservation treatment (
limited surgery followed by radiation).
7. 2. INVASIVE CANCER
a) infiltrating ductal carcinoma
accounts for 80% of all cases.
tumors arise from the duct system and invade the
surrounding tissue.
they often form a solid irregular mass in the breast.
b) infiltrating lobular carcinoma
accounts for 10% to 15% of breast cancer.
tumors arise from the lobular epithelium and
typically occur as an area of ill-defined thickening in
the breast.
8. c) medullary carcinoma
accounts for about 5% of breast cancer.
diagnosed more often in women younger than 50 years
of age.
Tumors grow in a capsule inside a duct .
They can become large .
d) mucinous carcinoma
accounts about 3% of breast cancer.
Often presents in postmenopausal women 75 years of age
and older.
Tumor is slow growing , prognosis is more favorable than
in many other types.
9. e) tubular ductal carcinoma
accounts for 2 % of breast cancer.
Axillary metastases are uncommon with this
histology.
Prognosis is usually excellent.
f) inflammation carcinoma
unique symptoms
Characterized by diffuse edema and brawny
erythema of the skin, referred to as peau d’orange.
Can spread to other parts of the body.
10. g) paget’s disease
accounts for 1% of breast cancer.
Symptoms include a scaly,erythematous , pruritic
lession of the nipple.
11. 1. FEMALE GENDER AGE
First-degree relative. Such as mother, sister, or
daughter.
2. MENSTRUAL HISTORY
Early menarche – (under age 12)
( late menopause after age 50 )
12. 3. RADIATION EXPOSURE
Chest x-ray, fluoroscopic examination, particularly
before age 30.
4. LIFE STYLE
High fat diet, alcohol intake greater than two drink
daily.
smoking
obesity
Breast trauma
13. Stage 0 – noninvasive carcinomas occupy their
locations of origin without spreading beyond this
point
Stage I – the tumor is no larger than two
centimeters, and cancer cells are confined to the
breast
Stage II – a tumor has started to spread to the
lymph nodes or, the tumor has exceeded five
centimeters in size
14. Stage III – the tumor has exceeded five centimeters
and has spread into the lymph nodes in a more
extensive way than in stage II
Stage IV – the cancer has metastasized and
spread to other regions of the body
15. 1. Breast mass or thickening.
2. unusual lump in the underarm or above
the colarbone.
3. Abnormal nipple discharge.
4. Rash around the nipple area.
5. Change in nipple position.
6. Burning, stinging or pricking sensation.
16. PERCUTANEOUS BIOPSY
1) percutaneous biopsy performed on an outpatient
basis to sample palpable and nonpalpable lesion.
2) is a needle or core bopsy that obtains tissue by
making small punture in the skin.
a) fine-needle aspiration
1) noninvasive biopsy technique.
2) need a small gauge needle ( 25 or 22 gauge).
3) suction is applied to the syringe.
17. 4) fluid is usually discarded.
5) less expensive than other diagnostic methods
and result are usually available quickly.
b) core needle biopsy
1) similar to fine-needle aspiration (FNA).
2) but used large gauge needle (usually 14 gauge).
3) a local anesthetic is applied, and tisssue cores are
removed.
4) more definitive diagnosis then FNA.
18. c) stereotactic core biopsy
1) performed on nonpalpable lesions detected by
mammography.
2) tissue are taken for pathologic examination.
3) quite accurate and often allows the patient to
avoid a surgical biopsy.
19.
20. 1. Chemotherapy
* The most common chemotherapy agents act
by killing cells that divide rapidly, one of the
main properties of most cancer cells. This
means that chemotherapy also harms cells that
divide rapidly under normal circumstances
21.
22. 2. Radiation Therapy
* is a highly targeted, highly effective way to
destroy cancer cells in the breast that may stick
around after surgery. Radiation can reduce the
risk of breast cancer recurrence by about 70%.
* Despite what many people fear, radiation
therapy is relatively easy to tolerate and its side
effects are limited to the treated area.
23.
24. 3. Breast lumps
* Less than one-fourth of all breast lumps are found to be
cancerous, but benign breast disease can be difficult to
distinguish from cancer. Consequently, all breast lumps
should be checked by a health care professional.
25.
26. 4. Mammography
* Mammography is a low-powered x-ray technique that
captures a picture of the internal structure of the breast.
* Additional angles and magnified views are taken of
suspicious areas. A mammogram may help in the diagnosis
of breast problems, including cancer.
27.
28. 5. CT scan
* a thin X-ray beam is rotated around the area of the
body to be visualized. Using very complicated
mathematical processes called algorithms, the computer is
able to generate a 3-D image of a section through the body.
* CT scans are very detailed and provide excellent
information for the physician.
29.
30. 6. Open biopsy of the breast
* An open biopsy can be performed under local or
general anesthesia and will leave a small scar. Prior to
surgery, a radiologist often first marks the lump with a
wire, making it easier for the surgeon to find.
31.
32. SURGICAL
1)LUMPECTOMY
A lumpectomy is surgery to remove a small area of breast tissue that is
cancerous.This surgery is carried out only in early breast cancer, if the area of tissue
to be removed is relatively small. Women who choose a lumpectomy will require
radiation therapy to destroy any cancer cells that may remain in the area.
2) MASECTOMY
A mastectomy is the surgical removal of the entire breast that is done in order to
remove a malignant tumour in cases of invasive breast cancer, with or without
removing the lymph nodes in the armpit. Sometimes, if more tissue needs to be
removed, a lumpectomy may be disfiguring and a mastectomy may be recommended
instead.
33. CHEMOTHERAPHY
i. Chemotheraphy tratment uses medicine to weaken and destroy cancer cells in
the body, including cells at the original cancer site and any cancer cells that may
have spread to another part of the body.
ii. Chemotheraphy is used to treat :
a) Early stage -invasive breast cancer to get rid of any cancer cells that may be left
behind after surgery and to reduce the risk of the cancer coming back.
b) Advanced stage-breast cancer to destroy or damage the cancer cells as much as
possible.
iii. Some cases, chemotherapy is given before surgery to shrink the cancer.
34. RADIATION THERAPHY
i. Radiation theraphy is also called radio theraphy is a highly targeted, highly
effective way to destroy cancer cells in the breast that may stick around after
surgery.
ii. Radiation therapy is relatively easy to tolerate and its side effects are limited to
the treated area.
radiation theraphy chemotheraphy
35. MEDICAL
Tamoxifen or aromatase inhibitor is recomanded for estrogen receptor-
positive (ER+) breast cancer. Its stop estrogen from fueling ER+ breast
cancer.
i. TAMOXIFEN
a) Medicine that blocks the effect of estrogen on breast cancer cells and
normal breast cells. But this medicine may also increase other risks, such
as for endometrial cancer, stroke and blood clots in veins and in the lungs.
36. ii. Aromatase Inhibitors
a) Letrozole (Femara)
b) Anastrozole (arimidex)
c) Exemestane (aromasin) are medicine that stop estrogen production in
postmenopausal women.
iii. Trastuzumab ( Herceptin )
a) Is recommended after surgery and chemotherapy for HER2/neu breast cancer.
This medicine is a monoclonal antibody that targets the HER-2 protein. It helps
chemotherapy work better.
iv. Serotonin antagonists, corticosteroids and phenothiazines
a) Treatment of breast cancer can cause nausea and vomitting. Doctor will be
prescribe this medicine to help relieve and prevent nausea and vomitting.
37. Destruction of the breast.
Destruction of the chest wall surrounding of the
breast.
Mastitis
Nipple discharge
Chest pain
Most women will have aches or pains from time to
time in the treated breast even years after treatment.
Hair loss after radiation therapy and chemotherapy.
38.
39.
40. the breast plays a significant role in a woman’s
sexuality and self –identity.
A breast disoder, wether benign or malignant, can
cause great anxiety and fear of potential
disfigurement, loss of sexual attractiveness, and even
death.
Must have expertise in the assessment and
management of not only the physical symptom but also
the psychosocial symptoms with breast disoders.
41. Madam Asiah age 35 years old admitted to the ward at
9 a.m she complaint of generalized abdominal pain 1/7
more on right sided region to the back. B/P :
110/62,Temperature : 38.5,Pulse : 65,Rate : 14. Doctor
has her’s Bilateral Breast Cancer stage iv and suggest
for the operation.
42. 1. Nursing Diagnosis :
Imbalanced nutrition ,less than body requirement
related to nausea and vomiting.
Goal :
Patient experiences less nausea and vomiting
associated with chemotherapy, weight loss is
minimized.
43. Intervension :
i. Assess the patient previous experiences and
expectation of nausea and vomiting, including cause
and intervension.
ii. Adjust diet before and after drug administration
according to patient preference and tolerance.
iii. Prevent unpleast sight,odor and sound in
environment.
iv. Ensure adequate fluid hydration,before during and
after drug administration ,assess intake and output.
v. Provide pain relief measure, if necessary.
vi. Assess other contribution factor to nausea and
vomiting such as other symptom, radiation
therapy, medication.
44. 2. Nursing Diagnosis :
Disturbed body image and situation low self- esteem
related to change in appearance, function and role.
Goal :
Improved body image and self-esteem.
45. Intervension :
i. Assess patient feeling about body image and level
of self- esteem.
ii. Encouraged continued participation in activities
and decision making.
iii. Assist patient in self- care when
fatigue,nausea,vomiting to prevent independence.
iv. Assist patient in selecting and using cosmetic,hair
pieces and clothing that increase sense of
attractiveness.
v. Individualize care for the patient.
47. Intervension :
i. Assess pain and discomfort characteristic use pain
scale.
ii. Assess other factor contributing to patient pain :
fear,fatigue.anger.
iii. Administer analgesic to promote optimum pain
relief.
iv. Assess patient behavioral responses to pain and
pain experiences.
v. Teach patient new strategies to relieve pain and
discomfort.
48. WAD PALIATIF CARE UNIT (PCU) HTAA
BRUNNER & SUDDARTH’S,Medical –Sergical Nursing,Twelthh
Edition.
http ://www.webmd.com/breast-cancer/tc/breast-cancer-
medications.